Cargando…
Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis
BACKGROUND: Prior clinical trials have suggested that home‐based Ig treatment in multifocal motor neuropathy (MMN) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and its variant Lewis–Sumner syndrome (LSS) is safe and effective and is less costly than hospital‐administered intr...
Autores principales: | Le Masson, Gwendal, Solé, Guilhem, Desnuelle, Claude, Delmont, Emilien, Gauthier‐Darnis, Marc, Puget, Sophie, Durand‐Zaleski, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822576/ https://www.ncbi.nlm.nih.gov/pubmed/29484273 http://dx.doi.org/10.1002/brb3.923 |
Ejemplares similares
-
Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study
por: Hachulla, Eric, et al.
Publicado: (2018) -
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study
por: Barnay, Marlène, et al.
Publicado: (2022) -
Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing
por: Roggenbuck, Dirk, et al.
Publicado: (2020) -
The European LEMS Registry: Baseline Demographics and Treatment Approaches
por: Mantegazza, Renato, et al.
Publicado: (2015) -
Olfaction and anosmia: From ancient times to COVID-19
por: Mathis, Stéphane, et al.
Publicado: (2021)